Quick Takeaways
- Richard H. Scheller has 6 issuer positions tracked on this page.
- Estimated disclosed ownership value: $3,166,964.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Richard H. Scheller
- Location
- South San Francisco, CA
- Summary
- The estimated net worth of Richard H. Scheller is at least $3,166,964 dollars as of 24 Sep 2025. Richard H. Scheller is the Director of BridgeBio Pharma, Inc. and owns shares of BridgeBio Pharma, Inc. (BBIO) stock worth about $2.42M. Richard H. Scheller is the Director of Oric Pharmaceuticals, Inc. and owns shares of Oric Pharmaceuticals, Inc. (ORIC) stock worth about $335.6K. Richard H. Scheller is the Director of 23andMe Holding Co. and owns shares of Chrome Holding Co. stock worth about $299.3K. Richard H. Scheller is the Director of Alector, Inc. and owns shares of Alector, Inc. (ALEC) stock worth about $110.6K.
- Signature
- /s/ Courtney Phillips, as attorney-in-fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Richard H. Scheller and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: BridgeBio Pharma, Inc. ($2,421,359).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Richard H. Scheller
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| BBIO | BridgeBio Pharma, Inc. | Director | $2,421,359 | 16 Feb 2023 | ||
| ORIC | Oric Pharmaceuticals, Inc. | Director | $335,640 | 20 May 2021 | ||
| ME | 23andMe Holding Co. | Director | $299,341 | 26 Aug 2024 | ||
| ALEC | Alector, Inc. | Director | $110,624 | 11 Jun 2025 | ||
| MAZE | Maze Therapeutics, Inc. | Director | $0 | -$464,035 | -100% | 22 Sep 2025 |
| DICE | DICE Therapeutics, Inc. | Director | 09 Aug 2023 |
Insider Transactions Reported by Richard H. Scheller:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.